Asia invests in latest laboratory tools for medicinal chemistry
Advertisement
Radleys has announced sales of its parallel chemistry and laboratory reactor products have contributed to a 400% growth in its Asian business during 2004-5 and 2005-6.
Reflecting on the spectacular business growth, Mark Radley (Managing Director) commented 'In recent years a growing proportion of our traditional pharmaceutical and biotech industry customers in Europe and North America have started to relocate part of their R&D to Asia. Consequently we have increased our resource allocation to the region and have seen companies including SABIC, Nicholas Piramal, Altana, GVK, Syngene, Dr Reddys, Advinus and Torrent investing in technology such as the Carousel, GreenHouse and Lara product ranges, to enable them to either win contracts from US or European pharma/biotech companies or to develop their own R&D programs'.
Most read news
Other news from the department business & finance
These products might interest you
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.